Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Fast-Paced presentation style boost COPD Patients' confidence?

NCT ID NCT07482033

Symptom relief Sponsor: Istanbul Saglik Bilimleri University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a special training method called Pecha Kucha can help people with COPD who use a breathing machine at home. The training aims to increase patients' confidence in managing their symptoms, reduce how much symptoms bother them, and make daily activities easier. About 60 adults with COPD will be split into two groups to compare the effects of this training versus usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 days and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Age 18 years or older * Diagnosed with chronic obstructive pulmonary disease (COPD) at least one year prior * Currently receiving treatment with noninvasive mechanical ventilation (NIMV) support * Ability to communicate verbally and in writing in a clear and sustainable manner * No severe visual or hearing impairment that would prevent understanding of educational materials * Basic ability to use a smartphone * Active use of the WhatsApp application on a personal smartphone * Technical capability to view educational materials sent via phone (e.g., internet access, video playback) * No prior education on NIMV delivered using the Pecha Kucha presentation technique * Adequate cognitive function to allow independent participation (e.g., no history of dementia or confusion) * Availability to attend educational and assessment sessions as scheduled Exclusion Criteria * Failure to attend planned educational sessions or inability to complete the study protocol * Voluntary withdrawal from the study, declared verbally or in writing * Death during the study period * Development of a serious health condition preventing continuation in the education program (e.g., hospitalization, acute exacerbation, deterioration in mental status) * Loss of phone or internet access preventing receipt of educational materials * Significant communication problems that substantially interfere with participation in the educational process

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Activities of daily living are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Activities of daily living Chronic obstructive pulmonary disease (COPD) Self efficacy Symptom severity

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.